|
1
|
Webb S and Dobb G: ARF, ATN or AKI? It’s
now acute kidney injury. Anaesth Intensive Care. 35:843–844.
2007.
|
|
2
|
Garcia-Tsao G, Parikh CR and Viola A:
Acute kidney injury in cirrhosis. Hepatology. 48:2064–2077. 2008.
View Article : Google Scholar
|
|
3
|
Sáenz-Morales D, Escribese MM, Stamatakis
K, García-Martos M, Alegre L, Conde E, Pérez-Sala D, Mampaso F and
García-Bermejo ML: Requirements for proximal tubule epithelial cell
detachment in response to ischemia: role of oxidative stress. Exp
Cell Res. 312:3711–3727. 2006.PubMed/NCBI
|
|
4
|
Thurman JM: Triggers of inflammation after
renal ischemia/reperfusion. Clin Immunol. 123:7–13. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boros P and Bromberg JS: New cellular and
molecular immune pathways in ischemia/reperfusion injury. Am J
Transplant. 6:652–658. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta S, Verfaillie C, Chmielewski D, et
al: Isolation and characterization of kidney-derived stem cells. J
Am Soc Nephrol. 17:3028–3040. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen YT, Sun CK, Lin YC, et al:
Adipose-derived mesenchymal stem cell protects kidneys against
ischemia-reperfusion injury through suppressing oxidative stress
and inflammatory reaction. J Transl Med. 9:512011. View Article : Google Scholar
|
|
8
|
Li B, Cohen A, Hudson TE, Motlagh D,
Amrani DL and Duffield JS: Mobilized human hematopoietic
stem/progenitor cells promote kidney repair after
ischemia/reperfusion injury. Circulation. 121:2211–2220. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bi B, Schmitt R, Israilova M, Nishio H and
Cantley LG: Stromal cells protect against acute tubular injury via
an endocrine effect. J Am Soc Nephrol. 18:2486–2496. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef
AA, Pei SN, Lee FY and Sun CK: Autologous bone marrow-derived
mononuclear cell therapy prevents the damage of viable myocardium
and improves rat heart function following acute anterior myocardial
infarction. Circ J. 72:1336–1345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dekel B, Shezen E, Even-Tov-Friedman S,
Katchman H, Margalit R, Nagler A and Reisner Y: Transplantation of
human hematopoietic stem cells into ischemic and growing kidneys
suggests a role in vasculogenesis but not tubulogenesis. Stem
Cells. 24:1185–1193. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szczypka MS, Westover AJ, Clouthier SG,
Ferrara JL and Humes HD: Rare incorporation of bone marrow-derived
cells into kidney after folic acid-induced injury. Stem Cells.
23:44–54. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sutton TA, Kelly KJ, Mang HE, Plotkin Z,
Sandoval RM and Dagher PC: Minocycline reduces renal microvascular
leakage in a rat model of ischemic renal injury. Am J Physiol Renal
Physiol. 288:F91–F97. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao J, Dennis JE, Muzic RF, Lundberg M and
Caplan AI: The dynamic in vivo distribution of bone marrow-derived
mesenchymal stem cells after infusion. Cells Tissues Organs.
169:12–20. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nagaya N, Fujii T, Iwase T, Ohgushi H,
Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K and Kitamura S:
Intravenous administration of mesenchymal stem cells improves
cardiac function in rats with acute myocardial infarction through
angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol.
287:H2670–H2676. 2004. View Article : Google Scholar
|
|
16
|
Luan Y, Zhang ZH, Wei DE, Lu Y and Wang
YB: Effects of autologous bone marrow mononuclear cells
implantation in canine model of pulmonary hypertension. Circ J.
76:977–985. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Semedo P, Palasio CG, Oliveira CD, et al:
Early modulation of inflammation by mesenchymal stem cell after
acute kidney injury. Int Immunopharmacol. 9:677–682. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Infanger M, Kossmehl P, Shakibaei M, et
al: Induction of three-dimensional assembly and increase in
apoptosis of human endothelial cells by simulated microgravity:
Impact of vascular endothelial growth factor. Apoptosis.
11:749–764. 2006. View Article : Google Scholar
|
|
19
|
Sementilli A and Franco M: Renal acute
cellular rejection: correlation between the immunophenotype and
cytokine expression of the inflammatory cells in acute
glomerulitis, arterial intimitis, and tubulointerstitial nephritis.
Transplant Proc. 42:1671–1676. 2010. View Article : Google Scholar
|
|
20
|
Ali T, Khan I, Simpson W, Prescott G,
Townend J, Smith W and Macleod A: Incidence and outcomes in acute
kidney injury: a comprehensive population-based study. J Am Soc
Nephrol. 18:1292–1298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grossini E, Molinari C, Pollesello P,
Bellomo G, Valente G, Mary D, Vacca G and Caimmi P: Levosimendan
protection against kidney ischemia/reperfusion injuries in
anesthetized pigs. J Pharmacol Exp Ther. 342:376–388. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lafrance JP and Miller DR: Acute kidney
injury associates with increased long-term mortality. J Am Soc
Nephrol. 21:345–352. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
da Silva LB, Palma PV, Cury PM and Bueno
V: Evaluation of stem cell administration in a model of kidney
ischemia-reperfusion injury. Int Immunopharmacol. 15:1609–1616.
2007.PubMed/NCBI
|
|
24
|
Bonventre JV and Zuk A: Ischemic acute
renal failure: an inflammatory disease? Kidney Int. 66:480–485.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li H and Nord EP: CD40 ligation stimulates
MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation
in proximal tubule cells. Am J Physiol Renal Physiol.
282:F1020–F1033. 2002.PubMed/NCBI
|
|
26
|
Deng J, Kohda Y, Chiao H, Wang Y, Hu X,
Hewitt SM, Miyaji T, McLeroy P, Nibhanupudy B, Li S and Star RA:
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal
injury. Kidney Int. 60:2118–2128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Imberti B, Morigi M, Tomasoni S, et al:
Insulin-like growth factor-1 sustains stem cell mediated renal
repair. J Am Soc Nephrol. 18:2921–2928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tögel F, Weiss K, Yang Y, Hu Z, Zhang P
and Westenfelder C: Vasculotropic, paracrine actions of infused
mesenchymal stem cells are important to the recovery from acute
kidney injury. Am J Physiol Renal Physiol. 292:F1626–F1635.
2007.PubMed/NCBI
|
|
29
|
Bussolati B, Tetta C and Camussi G:
Contribution of stem cells to kidney repair. Am J Nephrol.
28:813–822. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan L, Wu MJ, Sun HY, Xiong J, Zhang Y,
Liu CY, Fu LL, Liu DM, Liu HQ and Mei CL: VEGF-modified human
embryonic mesenchymal stem cell implantation enhances protection
against cisplatin-induced acute kidney injury. Am J Physiol Renal
Physiol. 300:F207–F218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hiroyoshi T, Tsuchida M, Uchiyama K,
Fujikawa K, Komatsu T, Kanaoka Y and Matsuyama H: Splenectomy
protects the kidneys against ischemic reperfusion injury in the
rat. Transpl Immunol. 27:8–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Morigi M, Introna M, Imberti B, et al:
Human bone marrow mesenchymal stem cells accelerate recovery of
acute renal injury and prolong survival in mice. Stem Cells.
26:2075–2082. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hagiwara M, Shen B, Chao L and Chao J:
Kallikrein-modified mesenchymal stem cell implantation provides
enhanced protection against acute ischemic kidney injury by
inhibiting apoptosis and inflammation. Hum Gene Ther. 19:807–819.
2008. View Article : Google Scholar
|
|
34
|
Hoste EA and Schurgers M: Epidemiology of
acute kidney injury: how big is the problem? Crit Care Med.
36(Suppl 4): S146–S151. 2008. View Article : Google Scholar : PubMed/NCBI
|
